Applications Cartilage

With hundreds of thousands of knee arthroscopies performed each year and over 16 million people affected by osteoarthritis in the U.S. alone, the need for functional cartilage replacements is significant.  At present, many surgical techniques to repair joint surfaces produce fibrocartilage and are associated with patient pain, significant recovery time and strict rehabilitation protocols.  Efforts to produce a suitable tissue engineered cartilage replacement have led researchers to consider the complex mechanical loading of cartilage in vivo.  Tissue engineers are now investigating the effects of various mechanical stimulation options within multiple 3-D cell culture environments.  Fluid pressurization and various axes of additional mechanical stimulation have been developed "in house" to this point.

BISS is committed to producing reliable bioreactors that allow researchers to focus on the effects of cell seeding density, scaffold material, growth factors, and stimulation regimes with respect to chondrocyte differentiation and extracellular matrix development.

Physiologic Requirements:
BISS CartiGen Solutions:
Convective Nutrient Transport: Perfusion Capabilities
Uniform Cell Density: Hydrogel Seeding
Native Physiological Structure and Function: Biomimetic in vitro Environment

The CartiGen architecture provides a physiologic support system that enhances metabolic conditions for cell growth and maintenance in a 3-D environment.  Physiologic parameters are feedback-controlled for culture reproducibility.  The flexible hardware and computer control systems allow for the development of a wide variety of automated experimental protocols with varying levels of complexity (frequency, force magnitude and application profile).


Did you know that BISS TGT has a wide range of products for Tissue Engineering and Regenerative Medicine (TERM) Applications? Our innovative material testing technology is the most comprehensive commercial solution for the TERM market! We are proud to present BISS TGT TERM.



  • Children's Mercy Hospital and Clinics
  • Cook Biotech
  • Drexel University
  • FDA Center for Devices and Radiological Health
  • Gel-Del Technologies
See Full List


  • The Challenges of Tissue Characterization

    The Challenges of Tissue Characterization TERM research is poised to change the way we know health care. This cutting-edge technology demands new tools and solutions that are able to keep up with the development in personalized medicine. Instron® is delivering those solutions.

    More Info
  • BISS featured in THE HINDU

    Bangalore Integrated System Solutions (BISS), a leading test equipment manufacturer, prides in not just ‘making in India’ but also in engaging Indian minds and hands for the same. BISS is a Bengaluru-based developer, manufacturer and exporter of digitally-controlled precision test systems for material and component characterisation in industry, R&D and academia.

    More Info
  • As Featured in Quality Magazine

    All parties recognize the importance of developing test standards and providing the est possible medical devices, but determining the best methods is a challenge.

    More Info
  • Instron TERM - Video

    See the magic of Instron TERM characterize tissue and culture cells.

    More Info
  • Biomedical Advances

    Instron TERM's quarterly newsletter is focused on research and product development challenges in the tissue engineering and regenerative medicine field. Topics include new customer applications, new Instron products, and technology innovation updates.

    More Info
  • Instron TERM sponsors ISACB Webinar Series

    Register today for the Winter 2015 Webinar on February 5, 2015. "Stem Cell Therapy for Cardiovascular Disease: From Cell to Heart" Robert Deans, PhD & Keith March, MD, PhD

    More Info
Bangalore Integrated System Solutions (P) ltd. — No. 497 E, 14th Cross, 4th Phase, , Peenya Industrial Area,, Bangalore , Karnataka 560058
+91 80 28360184 |
Copyright © 2015 - 2023 Bangalore Integrated System Solutions (P) ltd. . All Rights Reserved. BISS aquired Tissue Growth Technologies (TGT) v1.5